NERVGEN PHARMA CORP (NGEN.CA) Stock Balance Sheet
TSX-V:NGEN - TSX Venture Exchange - CA64082X2032 - Common Stock - Currency: CAD
| MRQ (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 16.93M | 5.60M | 4.11M | |||
| Cash Equivalents | 21.01M | 22.45M | N/A | N/A | N/A | |||
| Receivables | 102.23K | 27.03K | 64.00K | 62.59K | 122.50K | |||
| Other Current Assets | 834.07K | 669.91K | 427.58K | 540.75K | 2.03M | |||
| Total Current Assets | 21.94M | 23.15M | 17.42M | 6.20M | 6.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.86K | 295.28K | 2.69K | 2.00K | N/A | |||
| Intangibles | 478.91K | 431.40K | 473.15K | 471.39K | 509.61K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 513.99K | 726.69K | 475.84K | 473.39K | 509.61K | |||
| TOTAL ASSETS | 22.46M | 23.88M | 17.90M | 6.68M | 6.77M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 95.79K | 86.27K | N/A | N/A | N/A | |||
| Accrued Expenses | 2.36M | 892.14K | 451.47K | 420.05K | 249.64K | |||
| Accounts Payable | 457.29K | 2.00M | 352.55K | 171.77K | 501.92K | |||
| Other Current Liabilities | 10.34M | 7.24M | 274.06K | 163.25K | 172.39K | |||
| Total Current Liabilities | 13.25M | 10.22M | 1.08M | 755.07K | 923.95K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 33.23K | 197.19K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | 33.22K | 197.19K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 13.28M | 10.41M | 1.08M | 755.07K | 923.95K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -71.32M | -43.95M | -25.59M | -17.03M | -9.45M | |||
| Common Shares | 80.50M | 57.41M | 42.40M | 22.95M | 15.29M | |||
| Shares Outstanding | 70.19M | 58.78M | 46.19M | 35.17M | 29.35M | |||
| Tangible Book Value per Share | 0.12 | 0.22 | 0.35 | 0.15 | 0.18 | |||
| Total Shareholders' Equity | 9.18M | 13.46M | 16.82M | 5.92M | 5.84M | |||
| TOTAL LIABILITIES AND EQUITY | 22.46M | 23.88M | 17.90M | 6.68M | 6.77M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.01 | N/A | N/A | N/A | |||
| Current Ratio | 1.66 | 2.27 | 16.16 | 8.21 | 6.77 | |||
| Return On Assets (ROA) | -106.89% | -86.79% | -71.11% | -167.58% | -144.34% | |||
| Return On Equity (ROE) | -261.55% | -153.94% | -75.67% | -188.95% | -167.18% | |||
All data in CAD , ROIC based on taxRate of 0.25